CoActiHerb has multiple actions through the individual and combined properties of its 17 herbal ingredients:
Acacia arabica
(bark)
Achyranthes aspera
(root and seed)
Adhatoda vasica
(leaves)
Boswellia serrata
(resin)
Camellia sinensis
(green leaves)
Cinnamomum Zeylanicum
(bark)
Curcuma longa
(rhizome)
Elettaria cardamomum
(fruit)
Nigella sativa
(seed)
Piper longum
(fruit)
Piper nigrum
(fruit)
Plumbago indica
(root)
Solanum xanthocarpum
(fruit)
Syzygium aromaticum
(bud)
Tinospora cordifolia
(aerial portion)
Withania somnifera
(rhizome)
Zingiber officinale
(rhizome)
The plant extracts are scientifically researched and widely used for their medicinal properties. For instance, turmeric, or Curcuma longa, has been acknowledged for its incredible and healing properties. Curcumin, an active compound in turmeric, has been studied for its anti-inflammatory action in the lungs and its use in acute respiratory distress syndrome.
Piperine, a compound present in black pepper (Piper nigrum), can enhance curcumin absorption in the body up to 200%.
In patients facing delayed post-infection lung recovery and fatigue, CoActiHerb has been found to be beneficial due to its anti-inflammatory, anti-viral, immunomodulatory, antioxidant, and anticoagulant effects. Several ingredients of CoActiHerb have been shown to reduce inflammation and improve respiratory function, thereby alleviating fatigue and signs of respiratory illness such as breathlessness, especially important for patients recovering from lung infections.
Innovator: Dr. Lakshmi SubramanianPh.D. Microbiology
Dr. Lakshmi Subramanian lays great emphasis on advanced scientific validations and protocols for drug testing. A strong proponent of the application of plant systems towards human well-being, he has 30 years of experience in plant-based formulations.
Having led a team that developed 15 exclusive plant-only formulations to treat a host of diseases, including chronic obstructive pulmonary disease, rheumatoid arthritis and viral infections in the liver (Hepatitis A, C & E), he has long-standing experience in phase IV double-blind placebo-controlled studies with plant drug extracts at premiere institutions and hospitals.
Dr. Lakshmi Subramanian is also associated with the preclinical discovery and development of 11 plant-based products currently marketed globally. He is proficient in using chromatography techniques to separate compounds from plant extracts and identifying active drug compounds from proven plant extracts, starting from method development to effective quantification and large-scale purification.
The erstwhile Director in-charge and Governing Board Member of a reputed DSIR recognized research institution, Dr. Subramanian currently creates large scale herb extracts and blends.
